Abstract
Chemotherapy of trypanosomiasis and leishmaniasis is far from satisfactory and the discovery of new drugs has been slow. Emphasis on the empirical approach to drug development is now shifting towards a more rational, directed approach, which employs the modern tools of science. This is illustrated with respect to the newly discovered drug target, trypanothione, a unique metabolite which is critical for survival of Trypanosoma and Leishmania and absent from the host.
| Original language | English |
|---|---|
| Pages (from-to) | 613-617 |
| Number of pages | 5 |
| Journal | Transactions of the Royal Society of Tropical Medicine and Hygiene |
| Volume | 84 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - Sept 1990 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
ASJC Scopus subject areas
- Parasitology
- Public Health, Environmental and Occupational Health
- Infectious Diseases
Fingerprint
Dive into the research topics of 'Future prospects for the chemotherapy of human trypanosomiasis: 1. Novel approaches to the chemotherapy of trypanosomiasis'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver